CYC-116
Product Specifications
CAS Number
693228-63-6
Target
VEGFR|||FLT|||Aurora Kinase|||S6 Kinase|||CDK
Related Pathways
MAPK|||Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||PI3K/Akt/mTOR signaling|||Angiogenesis|||Cell Cycle/Checkpoint
Purity
0.9759
Bioactivity
CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM, is less potent to VEGFR2 (Ki of 44 nM), with 50-fold greater potency than CDKs, not active against PKA, Akt/PKB, PKC, no effect on GSK-3?/?, CK2, Plk1 and SAPK2A. Phase 1.
Smiles
Cc1nc(N)sc1-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1
Molecular Formula
C18H20N6OS
Molecular Weight
368.46
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/2C6F09E0-321D-4F84-9A09-D9D6B6B7CF74/T6458
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
VCDIN2R 344 / PCK
2ml Clear Type I Neutral Glass Injection Vial with 13mm Crimp Neck
Ask
View Details ![IKBKB Mouse Monoclonal Antibody [KD Validation]](https://cdn.genprice.uk/genprice/genprice4.png)